Phase 1 Stomach Cancer Trial, Recruiting NCT04147078 Sponsor: Sichuan University Condition: Stomach Cancer
Back to Stomach Cancer

Phase 1 Stomach Cancer Trial, Recruiting

NCT04147078
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have recently received their first diagnosis of stomach cancer, liver cancer, non-small cell lung cancer, or colorectal cancer, and have had surgery or ablation treatment with the goal of fully removing the cancer.
  • People whose doctors expect them to live for more than 3 months.
  • People who are fully active or have only minor limitations in daily activities, as measured by a standard medical scale called the ECOG performance status score of 0 or 1 (confirm with trial site).
  • People whose organs such as the liver, kidneys, and heart are functioning at an adequate level (confirm with trial site).

Who may not be able to join:

  • People whose cancer has spread to other parts of the body, or who have another type of cancer at the same time.
  • People experiencing a cancer-related emergency (confirm with trial site).
  • People who have abnormal blood clotting (confirm with trial site).
  • People who have certain infectious diseases, such as Hepatitis B, Hepatitis C, HIV, or tuberculosis.
  • People who have more than one tumour present at the same time (confirm with trial site).
  • People who have conditions affecting the immune system (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +86 028-85422589

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
Sichuan University
Registry
ClinicalTrials.gov
Start date
1 June 2019
Est. completion
31 December 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Disease-free Survival (DFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov